.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Healthtrust
Moodys
Chubb
Cipla
Fuji
McKesson
US Army
Teva

Generated: December 15, 2017

DrugPatentWatch Database Preview

GRISEOFULVIN,ULTRAMICROSIZE Drug Profile

« Back to Dashboard

When do Griseofulvin,ultramicrosize patents expire, and when can generic versions of Griseofulvin,ultramicrosize launch?

Griseofulvin,ultramicrosize is a drug marketed by Sigmapharm Labs Llc and is included in one NDA.

The generic ingredient in GRISEOFULVIN,ULTRAMICROSIZE is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.

Summary for GRISEOFULVIN,ULTRAMICROSIZE

Drug patent expirations by year for GRISEOFULVIN,ULTRAMICROSIZE

Pharmacology for GRISEOFULVIN,ULTRAMICROSIZE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sigmapharm Labs LlcGRISEOFULVIN,ULTRAMICROSIZEgriseofulvin, ultramicrosizeTABLET;ORAL202545-001Oct 22, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcGRISEOFULVIN,ULTRAMICROSIZEgriseofulvin, ultramicrosizeTABLET;ORAL202545-002Oct 22, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Express Scripts
Cipla
QuintilesIMS
Novartis
Chinese Patent Office
Argus Health
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot